No one wants to receive a diagnosis of blood cancer but if you or a loved one need to consider a bone marrow transplant, the care team at the Blood Cancer Center at The Jewish Hospital – Mercy Health is here to care for you.
The region’s most established blood cancer center recently earned re-certification and the Gold Seal of Approval® from the Joint Commission for its bone marrow transplant program. The Gold Seal of Approval® is a symbol of quality that reflects an organization’s commitment to providing safe and effective patient care.
Now in its 30th year of operation, The Jewish Hospital’s Blood Cancer Center underwent a rigorous on-site review to earn re-certification. Joint Commission experts evaluated compliance with national disease-specific care standards as well as with bone marrow transplant-specific requirements. They also assessed clinical practice guidelines and performance measures.
“The Jewish Hospital’s Blood Cancer Center has demonstrated thoroughly a high level of care for patients with blood cancers,” said Patrick Phelan, executive director, Hospital Business Development, The Joint Commission. “We commend The Jewish Hospital for being a leader in bone marrow transplant care and for providing a higher standard of service for blood cancer patients in its community.”
“Words can’t describe the bonds our Blood Cancer Center care team forms with patients and their loved ones. Caring for patients with blood cancer is a long-term proposition and everyone who comes through our doors becomes family,” said Pat Davis-Hagens, Mercy Health Central Market President and CEO. “Our greatest satisfaction comes from seeing patients get well. Third party-validation of our work from the Joint Commission, the premier health care quality improvement and accrediting body in the nation, is a bonus and an honor we share equally.”
The most recent data released by the Center for International Blood and Marrow Transplant Research (CIBMTR) shows that The Jewish Hospital Blood Cancer Center/OHC is comparable in outcomes to top cancer centers regionally and nationally in overall survival of adult blood and marrow transplant patients.
Most recently the Blood Cancer Center started a new CAR-T therapy program and is the only center in the region offering this treatment to relapsed-refractory non-Hodgkin’s lymphoma patients.
Each year, thousands of people develop blood diseases, such as leukemia, Hodgkin’s disease, non-Hodgkin’s lymphoma and multiple myeloma that are treatable with blood stem cell or bone marrow transplants. The Jewish Hospital – Mercy Health is the Tri-State leader in blood cancers and has been performing bone marrow transplants since 1993. Its team of skilled and compassionate professionals perform more than 100 blood and bone marrow transplants annually. For more information, please visit mercy.com.